» Articles » PMID: 9292280

Study of Oxidative-stress in Isoniazid-rifampicin Induced Hepatic Injury in Young Rats

Overview
Date 1997 Aug 1
PMID 9292280
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The role of oxidative-stress as a mechanism of hepatotoxicity caused by combination of isoniazid (INH) and Rifampicin (RMP) was investigated in young growing rats. A successful model of hepatotoxicity was produced by giving 50 mg/kg/day each of INH and RMP in two weeks. Liver showed type II hepatocellular changes (microvesicular fat deposition) with mild portal triaditis. The glutathione and related thiols were significantly decreased in both blood and liver tissues with combination of INH and RMP treatment. Superoxide dismutase, glutathione peroxidase, catalase and glutathione-S-transferases with CDNB and DCNB as substrates were decreased in the combination treated group. Glutathione reductase, glutathione-S-transferase with ethacrynic acid as substrate and lipid peroxidation exhibited a significant increase with treatment. The altered profile of antioxidant enzymes with increased lipid peroxidation indicated the enhanced oxidative-stress in combination of INH and RMP treatment. All the findings are faithfully reflected in the blood tissue except superoxide dismutase which showed significant enhancement in this tissue. INH and RMP hepatotoxicity is thus appeared to be mediated through oxidative-stress.

Citing Articles

Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Sankar J, Chauhan A, Singh R, Mahajan D Front Pharmacol. 2024; 15:1441147.

PMID: 39364056 PMC: 11447295. DOI: 10.3389/fphar.2024.1441147.


Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats.

Naji K, Al-Khatib B, Al-Haj N, Dsouza M BMC Pharmacol Toxicol. 2021; 22(1):39.

PMID: 34217369 PMC: 8254969. DOI: 10.1186/s40360-021-00507-9.


Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.

Chen S, Pan H, Chen Y, Lu L, He X, Chen H Sci Rep. 2019; 9(1):14311.

PMID: 31586142 PMC: 6778130. DOI: 10.1038/s41598-019-50706-y.


Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a H NMR based metabolomics approach.

Zhao H, Si Z, Li M, Jiang L, Fu Y, Xing Y Toxicol Res (Camb). 2018; 6(1):17-29.

PMID: 30090474 PMC: 6062402. DOI: 10.1039/c6tx00245e.


Hepatoprotective Evaluation of against Drug-induced Hepatotoxicity of Antitubercular Agents in Rats.

Hussain T, Subaiea G, Firdous H Pharmacogn Mag. 2018; 14(54):180-185.

PMID: 29720828 PMC: 5909312. DOI: 10.4103/pm.pm_237_17.